Aims and Scope

Aims

The Indo Eurasian Journal of Medical Sciences (IEJMS) is an international, peer-reviewed, open-access journal published bi-monthly by Scienceroot Publishers. IEJMS exists to strengthen the evidence base for clinical practice and health policy across the Indo-Eurasian corridor — South Asia, Central Asia, the Caucasus, the Middle East, and Eastern Europe — a region that carries a disproportionate share of the global disease burden while remaining under-represented in the indexed biomedical literature.

The journal's specific aims are:

• To publish methodologically rigorous original research that addresses health problems of demonstrable regional and international significance, including communicable disease, the epidemiological transition to non-communicable disease, maternal and child health, and health-systems capacity.
• To provide a venue in which research conducted in resource-constrained clinical and laboratory settings is evaluated on its methodological merit rather than on the wealth of the setting in which it was produced.
• To require, and make publicly verifiable, adherence to international reporting standards (CONSORT, PRISMA, STROBE, CARE, ARRIVE, and SPIRIT) so that work published in IEJMS is fit for inclusion in systematic reviews and evidence syntheses.
• To support reproducibility and open science through mandatory data-availability statements, trial and systematic-review pre-registration, and structured reporting of statistical methods.
• To develop regional research capacity through constructive, developmental double-blind peer review and through editorial mentoring of early-career authors.

Scope

IEJMS considers submissions across the following domains. Coverage is defined by the clinical or public-health question addressed, not by discipline label; submissions must present a testable question, an appropriate design, and conclusions that follow from the data.

Clinical medicine

Internal medicine and its subspecialties (cardiology, endocrinology and diabetes, gastroenterology and hepatology, nephrology, neurology, pulmonology, rheumatology, infectious diseases); general and subspecialty surgery, anaesthesiology, critical care and perioperative medicine; obstetrics and gynaecology; paediatrics and neonatology; psychiatry and mental health; dermatology, ophthalmology and otorhinolaryngology; emergency and trauma medicine; oncology and palliative care.

Public health, epidemiology and health systems

Observational and interventional epidemiology; surveillance and outbreak investigation; environmental, occupational and climate-related health; nutrition and food security; health economics, financing and access; health-services research, quality improvement and implementation science; health policy analysis; global and One Health approaches to zoonotic and antimicrobial-resistance threats.

Laboratory and translational biomedicine

Microbiology, virology, parasitology and antimicrobial resistance; immunology and vaccinology; medical genetics and genomics; clinical biochemistry, haematology and transfusion medicine; anatomic and molecular pathology; biomarker discovery and validation with a defined path to clinical application.

Pharmacology and therapeutics

Clinical pharmacology and pharmacokinetics; rational drug use, pharmacovigilance and drug safety; pharmacoepidemiology; clinical trials of drugs, devices and behavioural interventions; ethnopharmacology and traditional-medicine research reported to modern pharmacological standards, including full phytochemical characterisation and defined controls.

Medical imaging and informatics

Diagnostic and interventional radiology; nuclear medicine; AI and machine-learning applications in diagnosis, prognosis and triage, reported in accordance with CLAIM/TRIPOD-AI and accompanied by external validation, disclosure of training-data provenance, and fairness assessment; clinical decision support, digital health and telemedicine; health data science.

Nursing, allied health and medical education

Nursing science and patient-safety research; physiotherapy, rehabilitation and occupational therapy; dentistry and oral health; laboratory and radiographic technology; medical education research employing validated instruments and appropriate comparison groups.

Biomedical engineering

Medical devices, biomaterials and prosthetics evaluated in a clinical or preclinical context; point-of-care and low-cost diagnostic technologies suitable for resource-limited settings.

Article types

Original research articles; systematic reviews and meta-analyses; narrative and scoping reviews that critically synthesise rather than merely summarise a field; brief reports and short communications; study protocols with complete methodological detail; case reports and case series presenting a genuine advance in diagnosis or management, reported to CARE standards; letters to the editor; and invited editorials and commentaries.

Word limits and structural requirements for each type are set out in the Author Guidelines.

Geographic and authorship position

IEJMS is regionally focused in subject matter but international in authorship, editorial composition and readership. Submissions are welcomed from any country. The editorial board is constituted to reflect this, with members drawn from multiple countries and institutions, and no single institution holding a controlling share of board seats or of published authorship.

What we look for

• A clearly stated, original contribution, with the gap in existing knowledge explicitly identified.
• Methods described in sufficient detail for independent replication, including sample-size justification and pre-specified analysis plans.
• Reporting consistent with the relevant EQUATOR Network guideline, with the completed checklist supplied at submission.
• Documented ethics-committee approval and informed consent for all human-subjects research; institutional animal-care approval for animal research.
• Prospective registration for clinical trials (CTRI, ClinicalTrials.gov or another WHO ICTRP primary registry) and for systematic reviews (PROSPERO).
• A data-availability statement, and deposition of underlying data in a recognised repository where ethically and legally permissible.
• Full disclosure of funding sources and competing interests by every author, and ICMJE-compliant authorship with CRediT contributor roles.
• Conclusions proportionate to the evidence presented.

What we do not publish

IEJMS does not publish speculative work unsupported by data; studies lacking methodological detail sufficient for replication; human or animal research without documented ethics approval; unregistered clinical trials; work substantially published elsewhere; paper-mill or template-generated submissions; predatory-style bulk case reports without clinical lesson; or manuscripts whose stated conclusions exceed their design.